Device closure of residual shunt after percutaneous closure of patent foramen ovale

EuroIntervention. 2010 Feb;5(7):833-7. doi: 10.4244/eijv5i7a139.

Abstract

Aims: To summarise our experiences of device closure of residual shunt after transcatheter closure of patent foramen ovale (PFO).

Methods and results: Since October 1997 implantation of a second closure device was attempted in 40 patients with a moderate or large residual shunt after implantation of a PFO closure device. The mean age of the patients was 51 years. Implantation of a second closure device was technically successful in 39/40 patients (98 %). The following devices were implanted: Premere (n=20), Amplatzer PFO (n=13), STARFlex (n=4), Helex (n=1), Angelwings (n=1). During a mean follow-up of 36+/-29 months complete closure was achieved in 27 patients (69 %). The remaining shunt was small in nine patients, moderate in one and large in two. One patient with a moderate and one patient with a large residual shunt received a third device. The third patient was sent to surgery. One patient died 21 days after implantation of a third closure device due to acute pericardial tamponade. No other complications occurred.

Conclusions: Transcatheter implantation of a second closure device after PFO closure is feasible. Complete closure can be achieved in the majority of patients.

MeSH terms

  • Adult
  • Aged
  • Cardiac Catheterization / adverse effects
  • Cardiac Catheterization / instrumentation*
  • Cardiac Catheterization / mortality
  • Feasibility Studies
  • Female
  • Foramen Ovale, Patent / mortality
  • Foramen Ovale, Patent / physiopathology
  • Foramen Ovale, Patent / therapy*
  • Hemodynamics
  • Humans
  • Male
  • Middle Aged
  • Prosthesis Design
  • Recurrence
  • Septal Occluder Device*
  • Time Factors
  • Treatment Outcome
  • Young Adult